Search PepX: nuclear protein
33 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1GWQ | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
 |
  |
1GWR | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
|
  |
1MV9 | Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide | B | A | Nuclear receptor ligand-binding domain |
|
  |
1OBY | CRYSTAL STRUCTURE OF THE COMPLEX OF PDZ2 OF SYNTENIN WITH A SYNDECAN-4 PEPTIDE. | P | QBA | PDZ domain-like |
|
  |
1WBP | SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE | B | C |
|
|
  |
1YCQ | XENOPUS LAEVIS MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF HUMAN P53 | B | A | SWIB/MDM2 domain |
|
  |
2BSR | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | C | A | MHC antigen-recognition domain |
|
  |
2BZK | CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE | A | B |
|
|
  |
2C3I | CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I | A | B |
|
|
  |
2CCH | THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE | E | B | Cyclin-like |
|
  |
2CE8 | AN EH1 PEPTIDE BOUND TO THE GROUCHO-TLE WD40 DOMAIN. | X | A | 7-bladed beta-propeller |
|
  |
2CE9 | A WRPW PEPTIDE BOUND TO THE GROUCHO-TLE WD40 DOMAIN. | X | A | 7-bladed beta-propeller |
|
  |
2J7X | STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2J7Y | STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2JDS | STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654 | I | A | Protein kinase-like (PK-like) |
|
  |
2JDT | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE | I | A |
|
|
  |
2JDV | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 | I | A |
|
|
  |
2JF9 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST | P | AC |
|
|
  |
2UVX | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE | I | A |
|
|
  |
2UVY | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6-YL)-BENZYL)-AMINE | I | A |
|
|
  |
2UVZ | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-(9H-PURIN-6-YL)-PHENYL)-METHYLAMINE | I | A |
|
|
  |
2UW0 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE | I | A |
|
|
  |
2UW3 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-PYRAZOLE | I | A |
|
|
  |
2UW4 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE | I | A |
|
|
  |
2UW5 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE | I | A |
|
|
  |
2UW6 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE | I | A |
|
|
  |
2UW7 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE | I | A |
|
|
  |
2UW8 | STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE | I | A |
|
|
  |
2UZT | PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS | B | A |
|
|
  |
2UZU | PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS | I | E |
|
|
  |
2UZV | PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS | 2 | A |
|
|
  |
2UZW | PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS | I | E |
|
|
  |
3CS8 | Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a | B | A | Nuclear receptor ligand-binding domain |
|
